Filter
1005
Filtered Results: 1005
Text search:
immune
suppression
Featured
Recommendations
128
New Publications
240
Language
Document type
No document type
603
Guidelines
199
Studies & Reports
121
Manuals
27
Fact sheets
22
Training Material
12
Strategic & Response Plan
8
Infographics
6
Situation Updates
4
Brochures
2
Online Courses
1
Countries / Regions
India
67
Kenya
36
South Africa
33
Germany
24
Africa
19
Global
18
Tanzania
17
Ethiopia
17
Malawi
16
Zambia
16
Western and Central Europe
15
Nepal
13
Nigeria
13
Uganda
13
Latin America and the Carribbean
12
Zimbabwe
9
Philippines
9
Bangladesh
9
Myanmar / Burma
9
Ghana
8
Sierra Leone
8
South–East Asia Region
7
Rwanda
6
Asia
6
Brazil
6
Namibia
6
Eswatini/ Swaziland
6
Ukraine
5
Cambodia
5
Lesotho
4
Burkina Faso
4
Congo, Democratic Republic of
4
Eastern Europe and Central Asia
4
Russia
4
Cameroon
3
Albania
3
Mozambique
3
USA
3
West and Central Africa
3
Middle East and North Africa
3
East and Southern Africa
3
Botswana
3
Liberia
3
Timor Leste/ East Timor
2
Thailand
2
Benin
2
Senegal
2
Paraguay
2
Belgium
2
Eastern Europe
2
Georgia
2
Indonesia
2
Madagascar
2
North Korea
1
Switzerland
1
Colombia
1
Turkey
1
Gambia
1
Togo
1
China
1
Syria
1
Canada
1
Estonia
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Peru
1
Armenia
1
Haiti
1
Venezuela
1
Luxembourg
1
France
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Vietnam
1
Sri Lanka
1
Djibouti
1
Sudan
1
Yemen
1
Mali
1
Angola
1
Bhutan
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
343
Clinical Guidelines
140
Public Health
42
Women & Child Health
23
Key Resources
19
Capacity Building
13
Pharmacy & Technologies
7
Annual Report MEDBOX
1
Toolboxes
HIV
259
TB
119
COVID-19
108
NTDs
40
Rapid Response
35
AMR
24
Refugee
15
Mental Health
14
Planetary Health
12
Pharmacy
11
NCDs
10
Caregiver
9
Ebola & Marburg
8
Specific Hazards
4
Polio
4
Natural Hazards
3
Disability
2
Cholera
2
Health Financing Toolbox
2
Conflict
2
Zika
2
Global Health Education
2
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
This pocket guide offers basic information needed for the medical management of victims of radiation incidents in an easy-to-understand manner.
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Treat 3 Million by 2005
WHO/HIV/2005.02
African Region
September 2014
Monatsschrift Kinderheilkunde December 2015, Volume 163, Issü 12, pp 1269-1286.
Stellungnahme der Deutschen Gesellschaft für Pädiatrische Infektiologie, der Gesellschaft für Tropenpädiatrie und Internationale Kindergesundheit und des Berufsverbandes der Kinder- und Jugendärzte
Preliminary version for country introduction
Networking for Policy Change: TB/HIV Participant’s Guide
WHO/HTM/TB/2007.384b
“TB is too often a death sentence for people with AIDS. It does not have to be this
way.”
-Nelson Mandela, International conference on HIV and AIDS, Bangkok, Thailand, July 2004.
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Scientific advice
Prevention and control of communicable diseases in prison settings.
